Targeting of host-cell ubiquitin pathways by viruses

Essays in Biochemistry

Volumn 41, Issue , 2005, Pages 139-156

  Shackelford, Julia ^a,b   Pagano, Joseph S ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 27144443077     PISSN: 00711365     EISSN: None     Source Type: Journal    
DOI: 10.1042/bse0410139     Document Type: Review

References (39)

1. Knipe, D.M. & Howley, P.M. (eds) (2001) Fields Virology, 4th edn, Lippincott Williams & Wilkins, Philadelphia, PA
2. Pagano, J.S., Blaser, M., Buendia, M.A., Damania, B., Khalili, K., Raab-Traub, N. & Roizman, B. (2004) Infectious agents and cancer: criteria for a causal relation. Semin. Cancer Biol. 14, 453-471
3. Scheffner, M. & Whitaker, N.J. (2003) Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system. Semin. Cancer Biol. 13, 59-67
4. Frolov, M.V. & Dyson, N.J. (2004) Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J. Cell Sci. 117, 2173-2181
5. Dimova, D.K. & Dyson, N.J. (2005) The E2F transcriptional network: old acquaintances with new faces. Oncogene 24, 2810-2826
6. Oh, K.J., Kalinina, A., Wang, J., Nakayama, K., Nakayama, K.I. & Bagchi, S. (2004) The papillomavirus E7 oncoprotein is ubiquitinated by UbcH7 and Cullin I- and Skp2-containing E3 ligase. J. Virol. 78, 5338-5346
7. Liu, Y.C. (2004) Ubiquitin ligases and the immune response. Annu. Rev. Immunol. 22, 81-127
8. Vargas, D.A., Takahashi, S. & Ronai, Z. (2003) Mdm2: A regulator of cell growth and death. Adv. Cancer Res. 89, 1-34
9. Oren, M. (2003) Decision making by p53: life, death and cancer. Cell Death Differ. 10, 431-442
10. Hengstermann, A., Linares, L.K., Ciechanover, A., Whitaker, N.J. & Scheffner, M. (2001) Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells. Proc. Natl. Acad. Sci. U.S.A. 98, 1218-1223
11. Kao, W.H., Beaudenon, S.L., Talis, A.L., Huibregtse, J.M. & Howley, P.M. (2000) Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase. J. Virol. 74, 6408-6417
12. Ben-Israel, H. & Kleinberger, T. (2002) Adenovirus and cell cycle control. Front Biosci. 7, d1369-d1395
13. Russell, I.A., Royds, J.A. & Braithwaite, A.W. (2004) Exploitation of cell cycle and cell death controls by adenoviruses: the road to a productive infection. Prog. Mol. Subcell. Biol. 36, 207-243
14. Koike, K. (2002) Hepatocarcinogenesis in hepatitis viral infection: lessons from transgenic mouse studies. J. Gastroenterol. 37 (Suppl 13), 55-64
15. Anzola, M. (2004) Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis. J. Viral. Hepat. 11, 383-393
16. Stohwasser, R., Holzhutter, H.G., Lehmann, U., Henklein, P. & Kloetzel, P.M. (2003) Hepatitis B virus HBx peptide 116-138 and proteasome activator PA28 compete for binding to the proteasome alpha4/MC6 subunit. Biol. Chem. 384, 39-49
17. Wang, T., Wang, Y., Wu, M.C., Guan, X.Y. & Yin, Z.F. (2004) Activating mechanism of transcriptor NF-κB regulated by hepatitis B virus X protein in hepatocellular carcinoma. World J. Gastroenterol. 10, 356-360
18. Zhang, Z., Protzer, U., Hu, Z., Jacob, J. & Liang, T.J. (2004) Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner. J. Virol. 78, 4566-4572
19. Hagglund, R. & Roizman, B. (2004) Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus I. J. Virol. 78, 2169-2178
20. Everett, R.D. (2000) ICP0, a regulator of herpes simplex virus during lytic and latent infection. Bioessays 22, 761-770
21. Yu, Y., Wang, S.E. & Hayward, G.S. (2005) The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 22, 59-70
22. Holowaty, M.N., Sheng, Y., Nguyen, T., Arrowsmith, C. & Frappier, L. (2003) Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP. J. Biol. Chem. 278, 47753-47761
23. Shackelford, J. & Pagano, J.S. (2004) Tumor viruses and cell signalling pathways: deubiquitination versus ubiquitination. Mol. Cell. Biol. 24, 5089-5093
24. Balakirev, M.Y., Jaquinod, M., Haas, A.L. & Chroboczek, J. (2002) Deubiquitinating function of adenovirus proteinase. J. Virol. 76, 6323-6331
25. Shackelford, J., Maier, C. & Pagano, J.S. (2003) Epstein-Barr virus activates β-catenin in type III latently infected B lymphocyte lines: association with deubiquitinating enzymes. Proc. Natl. Acad. Sci. U.S.A. 100, 15572-15576
26. Rivett, A.J. & Hearn, A.R. (2004) Proteasome function in antigen presentation: immunoproteasome complexes, peptide production, and interactions with viral proteins. Curr. Protein Pept. Sci. 5, 153-161
27. Reinstein, E. (2004) Immunologic aspects of protein degradation by the ubiquitin-proteasome system. Isr. Med. Assoc. J. 6, 420-424
28. Collins, R.W. (2004) Human MHC class I chain related (MIC) genes: their biological function and relevance to disease and transplantation. Eur. J. Immunogenet. 31, 105-114
29. Harari, A., Zimmerli, S.C. & Pantaleo, G. (2004) Cytomegalovirus (CMV)-specific cellular immune responses. Hum. Immunol. 65, 500-506
30. Mocarski, Jr, E.S. (2004) Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system. Cell. Microbiol. 6, 707-717
31. Benichou, S. & Benmerah, A. (2003) The HIV nef and the Kaposi-sarcoma-associated virus K3/K5 proteins: "parasites" of the endocytosis pathway. Med. Sci. (Paris) 19, 100-106
32. Masucci, M.G. (2004) Epstein-Barr virus oncogenesis and the ubiquitin-proteasome system. Oncogene 23, 2107-2115
33. Morita, E. & Sundquist, W.I. (2004) Retrovirus budding. Annu. Rev. Cell Dev. Biol. 20, 395-425
34. Martin-Serrano, J., Eastman, S.W., Chung, W. & Bieniasz, P.D. (2005) HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway. J. Cell Biol. 168, 89-101
35. Martin-Serrano, J., Perez-Caballero, D. & Bieniasz, P.D. (2004) Context-dependent effects of L domains and ubiquitination on viral budding. J. Virol. 78, 5554-5563
36. Klinger, P.P. & Schubert, U. (2005) The ubiquitin-proteasome system in HIV replication: potential targets for antiretroviral therapy. Exp. Rev. Anti-infect. Ther. 3, 61-79
37. Li, F. & Wild, C. (2005) HIV-1 assembly and budding as targets for drug discovery. Curr. Opin. Investig. Drugs 6, 148-154
38. Dohmen, R.J. (2004) SUMO protein modification. Biochim. Biophys. Acta 1695, 113-131
39. Wilson, V.G. & Rangasamy, D. (2001) Intracellular targeting of proteins by sumoylation. Exp. Cell Res. 271, 57-65